Cohance Lifesciences Limited (NSE:COHANCE)

Cohance Lifesciences Revenue

Cohance Lifesciences had revenue of 4.89B INR in the quarter ending September 30, 2026, a decrease of -11.97%. This brings the company's total for the last twelve months to 20.57B, up 69.95% year-over-year. In the fiscal year ending March 31, 2026, Cohance Lifesciences had annual revenue of 22.69B, down -13.03%. That makes Cohance Lifesciences the 16,836th largest company in the world by revenue and 909th in India.

• Revenue (ttm): 20.57B
• Revenue Growth: +69.95%
• P/S Ratio: 8.79
• Revenue / Employee: 16.98M
• Employees: 1,212
• Market Cap: 180.76B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Europe 7.22B 32.2%
• USA 6.73B 30.0%
• Rest of The World 5.29B 23.6%
• India 3.17B 14.2%

Fiscal year ended Mar 31, 2026 See the full Cohance Lifesciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	22.69B	-3.40B	-13.03%
Mar 31, 2025	26.09B	15.57B	148.11%
Mar 31, 2024	10.51B	-2.89B	-21.56%
Mar 31, 2023	13.40B	201.07M	1.52%
Mar 31, 2022	13.20B	3.11B	30.75%

Data Source: S&P Global Market Intelligence Last updated: Nov 6, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 12, 2026

Data Sources Report a data error